BioLife Solutions Current Ratio 2010-2023 | BLFS
BioLife Solutions current ratio from 2010 to 2023. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
| BioLife Solutions Current Ratio Historical Data | |||
|---|---|---|---|
| Date | Current Assets | Current Liabilities | Current Ratio |
| 2023-12-31 | $0.12B | $0.04B | 2.86 |
| 2023-09-30 | $0.12B | $0.04B | 2.74 |
| 2023-06-30 | $0.12B | $0.04B | 3.04 |
| 2023-03-31 | $0.13B | $0.05B | 2.81 |
| 2022-12-31 | $0.14B | $0.05B | 3.11 |
| 2022-09-30 | $0.14B | $0.04B | 3.68 |
| 2022-06-30 | $0.12B | $0.03B | 3.55 |
| 2022-03-31 | $0.12B | $0.04B | 3.39 |
| 2021-12-31 | $0.13B | $0.04B | 2.95 |
| 2021-09-30 | $0.13B | $0.04B | 3.65 |
| 2021-06-30 | $0.13B | $0.03B | 4.07 |
| 2021-03-31 | $0.12B | $0.02B | 7.12 |
| 2020-12-31 | $0.12B | $0.02B | 7.37 |
| 2020-09-30 | $0.13B | $0.01B | 15.28 |
| 2020-06-30 | $0.05B | $0.01B | 6.18 |
| 2020-03-31 | $0.03B | $0.03B | 1.04 |
| 2019-12-31 | $0.02B | $0.01B | 3.14 |
| 2019-09-30 | $0.03B | $0.01B | 6.49 |
| 2019-06-30 | $0.03B | $0.00B | 9.42 |
| 2019-03-31 | $0.04B | $0.00B | 14.50 |
| 2018-12-31 | $0.04B | $0.00B | 19.37 |
| 2018-09-30 | $0.04B | $0.00B | 18.27 |
| 2018-06-30 | $0.02B | $0.00B | 11.31 |
| 2018-03-31 | $0.01B | $0.00B | 7.81 |
| 2017-12-31 | $0.01B | $0.00B | 6.56 |
| 2017-09-30 | $0.01B | $0.00B | 5.85 |
| 2017-06-30 | $0.01B | $0.00B | 5.43 |
| 2017-03-31 | $0.01B | $0.00B | 5.14 |
| 2016-12-31 | $0.01B | $0.00B | 4.08 |
| 2016-09-30 | $0.01B | $0.00B | 1.43 |
| 2016-06-30 | $0.01B | $0.00B | 2.17 |
| 2016-03-31 | $0.01B | $0.00B | 3.59 |
| 2015-12-31 | $0.01B | $0.00B | 4.04 |
| 2015-09-30 | $0.01B | $0.00B | 5.08 |
| 2015-06-30 | $0.01B | $0.00B | 8.01 |
| 2015-03-31 | $0.01B | $0.00B | 7.49 |
| 2014-12-31 | $0.01B | $0.00B | 9.64 |
| 2014-09-30 | $0.01B | $0.00B | 15.41 |
| 2014-06-30 | $0.01B | $0.00B | 21.98 |
| 2014-03-31 | $0.02B | $0.00B | 13.79 |
| 2013-12-31 | $0.00B | $0.00B | 1.15 |
| 2013-09-30 | $0.00B | $0.00B | 1.35 |
| 2013-06-30 | $0.00B | $0.00B | 1.28 |
| 2013-03-31 | $0.00B | $0.00B | 1.30 |
| 2012-12-31 | $0.00B | $0.00B | 1.19 |
| 2012-09-30 | $0.00B | $0.00B | 1.21 |
| 2012-06-30 | $0.00B | $0.00B | 1.48 |
| 2012-03-31 | $0.00B | $0.00B | 2.00 |
| 2011-12-31 | $0.00B | $0.00B | 2.00 |
| 2011-09-30 | $0.00B | $0.00B | 2.02 |
| 2011-06-30 | $0.00B | $0.00B | 2.00 |
| 2011-03-31 | $0.00B | $0.00B | 1.98 |
| 2010-12-31 | $0.00B | $0.00B | 2.39 |
| 2010-09-30 | $0.00B | $0.01B | 0.09 |
| 2010-06-30 | $0.00B | $0.01B | 0.10 |
| 2010-03-31 | $0.00B | $0.01B | 0.09 |
| 2009-12-31 | $0.00B | $0.00B | 2.50 |
| 2009-09-30 | $0.00B | $0.01B | 0.10 |
| 2009-06-30 | $0.00B | $0.01B | 0.09 |
| 2009-03-31 | $0.00B | $0.01B | 0.17 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.718B | $0.143B |
| BioLife Solutions has pioneered the next generation of preservation solutions designed to maintain the viability and health of cellular matter and tissues during freezing, transportation and storage. Based on their proprietary bio-packaging technology and a patented understanding of the mechanism of cellular damage and death, these products enable the biotechnology and medical community to address a growing problem that exists today. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $186.151B | 24.44 |
| Stryker (SYK) | United States | $123.816B | 30.70 |
| Medtronic (MDT) | Ireland | $105.535B | 14.94 |
| Boston Scientific (BSX) | United States | $98.780B | 32.84 |
| EssilorLuxottica (ESLOY) | France | $98.612B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $41.070B | 0.00 |
| Haleon (HLN) | United Kingdom | $37.534B | 29.36 |
| ResMed (RMD) | United States | $26.307B | 26.30 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.538B | 15.80 |
| Terumo (TRUMY) | Japan | $24.492B | 34.59 |
| Baxter (BAX) | United States | $20.044B | 14.62 |
| Koninklijke Philips (PHG) | Netherlands | $18.554B | 14.80 |
| Insulet (PODD) | United States | $11.641B | 61.12 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $10.422B | 0.00 |
| Demant (WILYY) | Denmark | $9.965B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $7.977B | 23.77 |
| BellRing Brands (BRBR) | United States | $7.070B | 38.01 |
| Lantheus Holdings (LNTH) | United States | $4.374B | 11.29 |
| Perrigo (PRGO) | Ireland | $4.174B | 11.94 |
| Haemonetics (HAE) | United States | $4.126B | 21.10 |
| GN Store Nord (GNNDY) | Denmark | $3.707B | 24.00 |
| Prestige Consumer Healthcare (PBH) | United States | $3.459B | 16.35 |
| Envista Holdings (NVST) | United States | $3.430B | 13.05 |
| QuidelOrtho (QDEL) | United States | $2.616B | 9.50 |
| Green Thumb Industries (GTBIF) | United States | $2.602B | 82.47 |
| Neogen (NEOG) | United States | $2.515B | 24.19 |
| ICU Medical (ICUI) | United States | $2.333B | 17.41 |
| TG Therapeutics (TGTX) | United States | $2.130B | 689.00 |
| Owens & Minor (OMI) | United States | $1.899B | 18.23 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.835B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.710B | 0.00 |
| Agios Pharmaceuticals (AGIO) | United States | $1.659B | 0.00 |
| National Vision Holdings (EYE) | United States | $1.471B | 45.81 |
| InMode (INMD) | Israel | $1.462B | 7.57 |
| LeMaitre Vascular (LMAT) | United States | $1.420B | 46.86 |
| AdaptHealth (AHCO) | United States | $1.241B | 9.34 |
| Warby Parker (WRBY) | United States | $1.185B | 0.00 |
| AtriCure (ATRC) | United States | $1.122B | 0.00 |
| MacroGenics (MGNX) | United States | $0.977B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.723B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.691B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.690B | 14.90 |
| Evolus (EOLS) | United States | $0.668B | 0.00 |
| Quanterix (QTRX) | United States | $0.605B | 0.00 |
| Jin Medical (ZJYL) | China | $0.600B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.539B | 11.67 |
| Valneva SE (VALN) | France | $0.528B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.481B | 0.00 |
| PetIQ (PETQ) | United States | $0.479B | 17.89 |
| ZimVie (ZIMV) | United States | $0.420B | 25.72 |
| Biote (BTMD) | United States | $0.413B | 3.93 |
| OraSure Technologies (OSUR) | United States | $0.404B | 6.68 |
| Surmodics (SRDX) | United States | $0.377B | 40.75 |
| Zynex (ZYXI) | United States | $0.366B | 42.15 |
| Aurora Cannabis (ACB) | Canada | $0.352B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.305B | 30.31 |
| Cerus (CERS) | United States | $0.305B | 0.00 |
| Sanara MedTech (SMTI) | United States | $0.291B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.254B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.246B | 15.01 |
| Organigram Holdings (OGI) | Canada | $0.195B | 0.00 |
| Veru (VERU) | United States | $0.192B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.180B | 0.00 |
| High Tide (HITI) | Canada | $0.179B | 0.00 |
| Omeros (OMER) | United States | $0.177B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.158B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.147B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.133B | 21.39 |
| Eagleford Energy (GRUSF) | United States | $0.126B | 63.55 |
| Jushi Holdings (JUSHF) | United States | $0.125B | 0.00 |
| InterCure (INCR) | Israel | $0.115B | 19.46 |
| Fonar (FONR) | United States | $0.106B | 9.14 |
| MariMed (MRMD) | United States | $0.101B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.098B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.095B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.092B | 0.00 |
| Safety Shot (SHOT) | United States | $0.091B | 0.00 |
| Brainsway (BWAY) | Israel | $0.081B | 0.00 |
| Chimerix (CMRX) | United States | $0.079B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.071B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.060B | 3.91 |
| United Health Products (UEEC) | United States | $0.050B | 0.00 |
| Apyx Medical (APYX) | United States | $0.046B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.044B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.043B | 0.00 |
| Bright Green (BGXX) | United States | $0.040B | 0.00 |
| ImmuCell (ICCC) | United States | $0.039B | 0.00 |
| United-Guardian (UG) | United States | $0.037B | 14.30 |
| Modular Medical (MODD) | United States | $0.036B | 0.00 |
| Exagen (XGN) | United States | $0.024B | 0.00 |
| Nephros (NEPH) | United States | $0.022B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.022B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| FSD PHARMA (HUGE) | Canada | $0.018B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.010B | 72.64 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Sharps Technology (STSS) | United States | $0.004B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.002B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |